FP
Highly rated in
30
conditions

Dr. Forbes D. Porter

National Institutes Of Health Clinical Center
Bethesda, MD
Highly rated in
30
conditions
Specialties:Pediatrics | Medical Genetics
Clinical Trials:Currently Recruiting for 3 Trials
Highly rated in
30
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Forbes D. Porter's experience treating your condition:
About Dr. Forbes D. Porter

Forbes Porter is a Pediatrics specialist and a Medical Genetics expert in Bethesda, Maryland. Porter is highly rated in 30 conditions, according to our data. His top areas of expertise are Smith-Lemli-Opitz Syndrome, Niemann-Pick Disease, Reticulohistiocytoma, and Opitz G BBB Syndrome. He is licensed to treat patients in Maryland.

His clinical research consists of co-authoring 147 peer reviewed articles and participating in 14 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Forbes D. Porter it is best to call his office and ask if your insurance is accepted.

Call to see if your plan is accepted.
Locations
10 Center Dr, Bethesda, MD 20892
Background & Education
Specialties
Pediatrics
Medical Genetics
Licenses
Clinical Genetics in MD
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials
Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C
Enrollment Status: Recruiting
Publish Date: December 15, 2022
Investigations Into Inborn Errors of Cholesterol Synthesis and Related Disorders
Enrollment Status: Recruiting
Publish Date: December 02, 2022
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Enrollment Status: Recruiting
Publish Date: November 14, 2022
Clinical and Basic Investigations Into Smith-Lemli-Opitz Syndrome
Enrollment Status: Completed
Publish Date: December 14, 2022
Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1
Enrollment Status: Terminated
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: VTS-270
Study Phase: Phase 1/Phase 2
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
Enrollment Status: Completed
Publish Date: July 23, 2021
Intervention Type: Drug
Study Phase: Phase 1
Exome Sequencing in Autistic Spectrum Disorder Patients With Altered Cholesterol Homeostasis
Enrollment Status: Completed
Publish Date: December 17, 2019
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation
Enrollment Status: Terminated
Publish Date: May 23, 2019
Intervention Type: Dietary Supplement
Study Phase: Not Applicable
Cholesterol in Autism Spectrum Disorder (ASD): Characterization and Treatment
Enrollment Status: Completed
Publish Date: July 05, 2018
Intervention Type: Other
Study Phase: Phase 1/Phase 2
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Enrollment Status: Completed
Publish Date: February 22, 2018
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation
Enrollment Status: Withdrawn
Publish Date: July 02, 2017
Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
Enrollment Status: Completed
Publish Date: January 29, 2016
Intervention Type: Dietary Supplement
Study Phase: Phase 2
Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Enrollment Status: Completed
Publish Date: June 06, 2014
Intervention Type: Drug
Study Phase: Phase 2
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
Enrollment Status: Completed
Publish Date: May 06, 2013
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 11 Less Clinical Trials -
148 Total Publications
Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C disease.
Journal: JCI insight
Published: October 27, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
MT
Dr. Mendel Tuchman
Medical Genetics | Pediatrics
Highly rated in
8
conditions
Medical Genetics
Pediatrics

Main Hospital

111 Michigan Ave Nw, 
Washington, DC 
 7.2 mi

Mendel Tuchman is a Medical Genetics specialist and a Pediatrics expert in Washington, Washington, D.c.. Tuchman is highly rated in 8 conditions, according to our data. His top areas of expertise are N-Acetylglutamate Synthase Deficiency, Urea Cycle Disorders (UCD), Ornithine Transcarbamylase Deficiency, and Inborn Amino Acid Metabolism Disorder. He is licensed to treat patients in District of Columbia.

CT
Dr. Cynthia J. Tifft
Medical Genetics
Highly rated in
11
conditions
Medical Genetics

111 Michigan Ave Nw, 
Washington, DC 
 7.2 mi

Cynthia Tifft is a Medical Genetics expert in Washington, Washington, D.c.. Tifft is highly rated in 11 conditions, according to our data. Her top areas of expertise are Gangliosidosis, GM1 Gangliosidosis, Tay-Sachs Disease, and Sandhoff Disease. She is licensed to treat patients in District of Columbia.

NA
Dr. Nicholas Ah Mew
Medical Genetics | Pediatrics
Highly rated in
9
conditions
Medical Genetics
Pediatrics

Childrens National

Childrens National Medical Center

111 Michigan Ave Nw, 
Washington, DC 
 7.2 mi

Nicholas Ah Mew is a Medical Genetics specialist and a Pediatrics expert in Washington, Washington, D.c.. Ah Mew has been practicing medicine for over 21 years and is highly rated in 9 conditions, according to our data. His top areas of expertise are Urea Cycle Disorders (UCD), Propionic Acidemia, Inborn Amino Acid Metabolism Disorder, and Maple Syrup Urine Disease. He is licensed to treat patients in District of Columbia. Ah Mew is currently accepting new patients.